1. Prevalence of ClFA and ClFB Genes in Staphylococcus Aureus Isolated from Patient with Urinary Tract Infection in Al-Diwaniya City/ Iraq
- Author
-
Jabbar, Ali Sabri and Jabbar, Ali Sabri
- Abstract
Background: Staphylococcus aureus is a major nosocomial pathogen responsible for a vast array of infections, including urinary tract infections (UTIs). Biofilm formation, mediated by factors like ClfA and ClfB proteins, contributes to S. aureus pathogenesis. This study aimed to investigate the occurrence of ClfA and ClfB genes alongside the antimicrobial susceptibility testing of S. aureus isolates from patients with UTIs. Methods: A total of 42 S. aureus isolates were recovered from patients diagnosed with UTIs attended to private clinics in Al-Diwaniya city/ Iraq during January to May 2023. Identification was confirmed using the VITEK-2 system. Antimicrobial susceptibility testing was done by the Kirby-Bauer method against a panel of commonly used antibiotics. Conventional PCR was employed to detect the presence of ClfA and ClfB genes. Results: The study revealed high resistance rates were observed for Ampicillin (100%), Ampicillin/Cloxacillin (83.3%), Cefoxitin (78.6%), and Amikacin (73.8%) and Methicillin (71.4%). Conversely, resistance rates were lower for Meropenem (19.0%), Ciprofloxacin (21.4%), and Vancomycin (35.7%), indicating their potential continued use for UTI treatment. PCR analysis demonstrated a high occurrence of ClfA and ClfB genes within the S. aureus population. A significant majority (92.85%) of isolates harbored the ClfA gene while, 76.2% of isolates possessed the ClfB gene, highlighting its potential contribution to S. aureus pathogenesis in UTIs. Conclusion: ClfA and ClfB is highly distributed in S. aureusa, studies needed to evaluate molecular pattern of these genes and relationship with other virulence factors. Results of the present study highlight the need for continued invastigation of antibiotic resistance profile in S. aureus across in the country.
- Published
- 2024